Today: 20 May 2026
London Stock Exchange Group share price slides again as AI fears keep hitting LSEG stock

London Stock Exchange Group share price slides again as AI fears keep hitting LSEG stock

London, Feb 4, 2026, 10:45 GMT — Regular session

Shares of London Stock Exchange Group plc (LSEG.L) slipped roughly 1.8% to 7,048 pence by 10:39 GMT, after dipping as low as 6,684 pence earlier. That kept the stock close to a new 52-week low.

The decline stretched a two-day selloff in software and data stocks, sparked by Anthropic’s latest moves that revived fears faster AI tools could erode subscription revenue and future growth estimates. JP Morgan’s Toby Ogg noted investors seem to be “sentenced before trial,” with little enthusiasm to buy the dip. Reuters

Worries have spilled over from just software. Investors fear “AI agents” — tools capable of handling instructions and managing tasks across multiple apps — will improve quickly and force a rethink on the value of data, workflows, and compliance products.

“Anthropic is now, quite clearly, parking its tanks on their lawn,” said IG chief markets strategist Chris Beauchamp, summing up the mounting pressure on sector business models. The European Central Bank and Bank of England both hold meetings Thursday, setting the stage to challenge risk appetite following the sudden repricing. Reuters

Anthropic rolled out plug-ins for its Claude Cowork agent on Friday, aiming to automate jobs in legal, sales, marketing, and data analysis, Reuters reported. “Sometimes the market just shoots first and asks questions later,” said Mike Archibald, a portfolio manager at AGF Investments, as shares in companies linked to legal and data workflows took a steep hit. Reuters

LSEG revealed it purchased 253,226 ordinary shares on Feb. 3 under its buyback plan, at an average price of 7,685.36 pence each, with the intention to cancel them. Following this, the company will have 507,012,183 voting shares outstanding, not counting treasury stock.

LSEG operates across financial markets infrastructure and data services, covering Data & Analytics, the FTSE Russell index business, Risk Intelligence, Capital Markets, and Post Trade services, per a Reuters company profile. This broad offering means traders often group it with workflow and analytics companies when sentiment shifts against “software” exposure. Reuters

On Tuesday, LSEG tumbled 12.7% amid a broader AI-driven selloff that pushed the UK technology index down 11.8%. The FTSE 100 slipped 0.26%, Reuters reported. “Risk appetite just isn’t fully restored,” noted Swissquote Bank analyst Ipek Ozkardeskaya, as investors brace for Thursday’s Bank of England decision. Reuters

LSEG holders now face a key question: is this just a sudden jolt sparked by new product news, or the beginning of a gradual decline as investors rethink their long-term bets? The sharp swings over two sessions cloud the real price signal; liquidity appears briefly, then vanishes.

The decline might deepen if additional AI tools target revenue-generating data and professional workflows, or if companies opt to develop in-house solutions rather than renew contracts. Another round of sessions like this could push the selloff beyond a sector hiccup, turning it into a wider de-rating.

Traders will be on the lookout for whether the sell-off spreads to other UK defensives or remains focused on stocks linked to data, compliance, and workflow products. If bargain hunters return, expect them to pick their spots rather than dive in all at once.

LSEG is set to release its preliminary results for the year ended Dec. 31, 2025, on Feb. 26, per its investor relations calendar.

Stock Market Today

  • Parabilis Plans IPO to Fund Phase 3 Trial for Tumor Drug Following Regeneron Deal
    May 20, 2026, 5:56 AM EDT. Parabilis Medicines, a Massachusetts biotech, is preparing for an initial public offering (IPO) to finance the phase 3 trial of its tumor drug zolucatetide, targeting rare desmoid tumors. The drug, which inhibits the Wnt/β-catenin pathway implicated in many cancers, recently received FDA fast-track status. Proceeds will also support phase 1 trials for additional cancers. Parabilis secured a $50 million upfront payment and a $75 million equity investment from Regeneron in a deal to explore Parabilis' helicon peptide platform. The firm boasts over $300 million in cash from prior funding rounds. CEO Mathai Mammen aims to grow Parabilis into a fully integrated research, development, manufacturing, and commercialization company, relying on partnerships to finance its ambitions.

Latest articles

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

20 May 2026
OCI Energy and CPS Energy have begun building a 120-megawatt battery storage facility in southeastern Bexar County, aiming for commercial operation in 2027. The project follows a rise in average outage duration for CPS Energy customers to 75.38 minutes in 2025. OCI will own the facility, with CPS holding operational control. ING is financing construction, and LG Energy Solution Vertech is supplying batteries.
Co-Diagnostics Jumps; $3 Million Deal Looms

Co-Diagnostics Jumps; $3 Million Deal Looms

20 May 2026
Co-Diagnostics announced a $3 million private placement after its stock surged 43.8% Tuesday, then fell 13.3% in after-hours trading. The company will sell 1.65 million shares or pre-funded warrants, plus warrants for up to 3.29 million more shares, nearly doubling its share count. The move follows its completion of a Bundibugyo virus assay as Ebola spreads in Congo and Uganda. Co-Diagnostics reported $8.2 million in cash at March 31.
Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

20 May 2026
Micron Technology shares rose 2.5% Tuesday to $698.74, lifting its market value near $798 billion as the Nasdaq fell. Analysts cited tight memory supply and strong DRAM and NAND pricing. A planned strike by 48,000 Samsung workers Thursday could disrupt global memory supply, potentially raising prices. Micron recently sampled 256GB DDR5 server modules to partners.
Take-Two (TTWO) stock eyes a sharp open after forecast raise, GTA VI date held
Previous Story

Take-Two (TTWO) stock eyes a sharp open after forecast raise, GTA VI date held

Intel stock slides after CEO flags new GPU push; investors eye Nvidia’s next readout
Next Story

Intel stock slides after CEO flags new GPU push; investors eye Nvidia’s next readout

Go toTop